Biological Product (except Diagnostic) Manufacturing government contracts, bids & RFPs
NAICS 325414 · 5 open opportunities · 0 awards on record
This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic). Cross-References. Establishments primarily engaged in--
Paste your website — we'll show the open government contracts that fit your business.
Free · no signup · we read your homepage once. We don't store your email.
By the numbers
5 open Biological Product (except Diagnostic) Manufacturing opportunities; none currently set aside.
Biological Product (except Diagnostic) Manufacturing contract activity
A current snapshot based on 5 listings shown on this page. Counts update with the directory.
- Federal (SAM.gov)5
Deadline outlook
- Next 30 days
- 5
- Later
- 0
- Open / rolling
- 0
Most represented buyers
- DEFENSE LOGISTICS AGENCY3
- NATIONAL INSTITUTES OF HEALTH2
5 of the listings shown were posted in the last 30 days. Federal (SAM.gov) contributes the largest share (5). DEFENSE LOGISTICS AGENCY is the most represented buyer in this snapshot.
Open opportunities
- Leptin Protein (26-006897)HEALTH AND HUMAN SERVICES, DEPARTMENT OF / NATIONAL INSTITUTES OF HEALTH
The National Institute of Health (NIH) intends to negotiate and award a purchase order without providing for full and open competition to BIO-TECHNE SALES CORP. The purpose of this requirement is to provide a firm-fixed-price contract for Recombinant Rat Leptin Protein in the Critical Care Medicine Department within the NIH Clinical Center. The Critical Care Medicine Department conducts active research programs in bedside clinical investigation, research in animal models, and molecular…
MoreDue Aug 26, 2026Posted Aug 19, 2026 - Due Sep 1, 2026Posted Aug 21, 2026
- 2027 Southern Hemisphere Influenza VaccineDEPT OF DEFENSE / DEFENSE LOGISTICS AGENCY
The Defense Logistics Agency Troop Support is soliciting for the supply of Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. Approximately 30,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be a pre-measured 0.5 ML dose, each dose shall be pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. The vaccine…
MoreDue Sep 3, 2026Posted Aug 20, 2026 - Injectable Egg-Free Influenza Vaccine 2027DEPT OF DEFENSE / DEFENSE LOGISTICS AGENCY
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Egg-Free Influenza Vaccine for the 2027-2028 flu season. Approximately 300,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for immunizing individuals 18 years and older. The formula for the 2027-2028 season shall be determined by the U.S.…
MoreDue Sep 7, 2026Posted Aug 24, 2026 - Injectable Influenza VaccineDEPT OF DEFENSE / DEFENSE LOGISTICS AGENCY
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2027-2028 flu season. Approximately 1.5 million doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for the following age categories: for immunizing individuals 65 years and older, for immunizing individuals 18 years and…
MoreDue Sep 7, 2026Posted Aug 24, 2026
Related NAICS codes
Frequently asked
None of the 5 currently-open Biological Product (except Diagnostic) Manufacturing opportunities are set aside; they are open to all qualified vendors.